Endothelin ET


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Apr 2021
Historique:
received: 15 03 2021
revised: 16 04 2021
accepted: 19 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 20 5 2021
Statut: epublish

Résumé

In brain disorders, reactive astrocytes, which are characterized by hypertrophy of the cell body and proliferative properties, are commonly observed. As reactive astrocytes are involved in the pathogenesis of several brain disorders, the control of astrocytic function has been proposed as a therapeutic strategy, and target molecules to effectively control astrocytic functions have been investigated. The production of brain endothelin-1 (ET-1), which increases in brain disorders, is involved in the pathophysiological response of the nervous system. Endothelin B (ET

Identifiants

pubmed: 33919338
pii: ijms22094333
doi: 10.3390/ijms22094333
pmc: PMC8122402
pii:
doi:

Substances chimiques

Endothelin-1 0
Receptor, Endothelin B 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 18K06695

Références

Pharmacol Res. 2011 Jun;63(6):525-31
pubmed: 21193044
Mol Pharmacol. 2003 Sep;64(3):689-95
pubmed: 12920205
J Neurophysiol. 2011 Dec;106(6):2876-87
pubmed: 21900512
Commun Biol. 2019 Jun 21;2:236
pubmed: 31263780
J Clin Neurosci. 1995 Jul;2(3):252-6
pubmed: 18638823
Pharmacol Rev. 2016 Apr;68(2):357-418
pubmed: 26956245
Curr Pharm Des. 2004;10(18):2185-92
pubmed: 15281894
Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
Biophys J. 2008 Jul;95(1):483-92
pubmed: 18424490
Glia. 2000 May;30(3):253-70
pubmed: 10756075
Exp Neurol. 2012 Apr;234(2):362-72
pubmed: 22036747
Neurosci Lett. 2021 Jan 10;741:135393
pubmed: 33279571
Am J Pathol. 2009 Jul;175(1):262-70
pubmed: 19541930
Neuroscience. 2015 Aug 20;301:1-11
pubmed: 26022359
Int J Mol Sci. 2019 Jan 29;20(3):
pubmed: 30699952
J Neurochem. 2012 Mar;120(5):710-20
pubmed: 22145815
Neuropathol Appl Neurobiol. 2010 Oct;36(6):487-97
pubmed: 20345647
J Neurochem. 2004 Aug;90(4):904-12
pubmed: 15287896
Neurochem Int. 2011 Feb;58(3):261-72
pubmed: 21130129
Biochem Biophys Res Commun. 2004 Jun 4;318(3):642-8
pubmed: 15144886
Brain. 2011 Apr;134(Pt 4):1127-39
pubmed: 21371995
Physiol Rev. 2018 Jan 1;98(1):239-389
pubmed: 29351512
Cardiovasc Drug Rev. 2006 Spring;24(1):63-76
pubmed: 16939634
Mol Pharmacol. 2017 Jul;92(1):57-66
pubmed: 28461586
Glia. 1992;5(4):239-50
pubmed: 1316873
Pharmacol Ther. 2019 Feb;194:145-160
pubmed: 30291906
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3737-45
pubmed: 17652746
Am J Physiol Cell Physiol. 2006 Jul;291(1):C155-64
pubmed: 16452160
J Med Chem. 2012 Sep 13;55(17):7849-61
pubmed: 22862294
Mol Pharmacol. 2002 Jul;62(1):75-80
pubmed: 12065757
Glia. 1995 Oct;15(2):119-30
pubmed: 8567063
Eur J Neurosci. 1997 May;9(5):895-901
pubmed: 9182942
Trends Pharmacol Sci. 2007 Jun;28(6):296-302
pubmed: 17482681
Stroke. 2001 Sep;32(9):2143-8
pubmed: 11546909
Endocrinology. 1993 Feb;132(2):524-9
pubmed: 7678793
J Pharmacol Sci. 2009 Dec;111(4):338-51
pubmed: 19942800
Front Neurosci. 2020 Jul 28;14:824
pubmed: 32848579
FASEB J. 2011 Jan;25(1):16-28
pubmed: 20837776
Front Cell Neurosci. 2018 Nov 27;12:432
pubmed: 30538622
Cell Commun Signal. 2020 Apr 15;18(1):62
pubmed: 32293472
Biochem Biophys Res Commun. 1992 Jul 15;186(1):355-62
pubmed: 1378726
J Neurochem. 1993 Jan;60(1):260-6
pubmed: 8417145
Glia. 1999 Jun;26(4):324-32
pubmed: 10383051
J Pharmacol Exp Ther. 1993 Mar;264(3):1040-6
pubmed: 8450448
Neurochem Int. 2021 Jun;146:105042
pubmed: 33838160
J Neurosci. 2016 Nov 23;36(47):11929-11945
pubmed: 27881779
J Cardiovasc Pharmacol. 1995;26 Suppl 3:S393-6
pubmed: 8587424
J Cereb Blood Flow Metab. 1994 Mar;14(2):337-42
pubmed: 8113329
Brain Res. 2012 Jun 29;1464:14-23
pubmed: 22580085
Stroke. 1992 Jul;23(7):1014-6
pubmed: 1615534
Nat Med. 2006 Jul;12(7):829-34
pubmed: 16783372
J Neurosci Res. 2017 Dec;95(12):2430-2447
pubmed: 28467650
Glia. 1996 Apr;16(4):342-50
pubmed: 8721674
Eur J Neurosci. 2003 Aug;18(4):887-94
pubmed: 12925014
Glia. 2003 Feb;41(3):237-46
pubmed: 12528179
J Alzheimers Dis. 2012;29(4):853-61
pubmed: 22330820
J Neurochem. 2006 Feb;96(4):973-82
pubmed: 16412096
Immunity. 2017 Jun 20;46(6):957-967
pubmed: 28636962
J Neurosci. 2004 May 26;24(21):5016-21
pubmed: 15163694
Brain Res. 2013 Aug 28;1528:28-41
pubmed: 23850649
J Neurotrauma. 2010 Feb;27(2):361-71
pubmed: 19852587
J Neurotrauma. 2018 Jul 1;35(13):1481-1494
pubmed: 29316834
Trends Neurosci. 2009 Dec;32(12):638-47
pubmed: 19782411
Biochem Biophys Res Commun. 2003 Jan 17;300(3):661-8
pubmed: 12507500
J Med Chem. 1999 Sep 9;42(18):3668-78
pubmed: 10479298
Front Pharmacol. 2015 Nov 20;6:276
pubmed: 26635606
Can J Physiol Pharmacol. 2008 Aug;86(8):526-35
pubmed: 18758500
J Pharmacol Sci. 2010;114(4):433-43
pubmed: 21127388
Biochem Biophys Res Commun. 1989 Oct 16;164(1):74-80
pubmed: 2508641
J Cereb Blood Flow Metab. 2015 Oct;35(10):1687-96
pubmed: 26104290
Trends Immunol. 2016 Sep;37(9):608-620
pubmed: 27443914
Glia. 1999 May;26(3):268-71
pubmed: 10340767
Aging Dis. 2019 Jun 01;10(3):664-675
pubmed: 31165009
FASEB J. 2007 Mar;21(3):777-89
pubmed: 17197385
Br J Pharmacol. 2008 May;154(1):13-24
pubmed: 18362896
J Biol Chem. 2019 Mar 15;294(11):3920-3933
pubmed: 30670587
J Neurochem. 1996 Feb;66(2):459-65
pubmed: 8592114
Cell. 1994 Dec 30;79(7):1277-85
pubmed: 8001160
J Biol Chem. 2001 Jul 6;276(27):24540-8
pubmed: 11337485
Cell Signal. 2012 Jan;24(1):86-98
pubmed: 21872657
Neurobiol Aging. 2006 Mar;27(3):446-50
pubmed: 15894408
Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8726-31
pubmed: 26124113
J Biol Chem. 1994 Jan 21;269(3):1845-51
pubmed: 8294432
Science. 2014 Oct 10;346(6206):237-41
pubmed: 25301628
Biochem Biophys Res Commun. 2008 Jul 11;371(4):659-63
pubmed: 18439420
Biochem Biophys Res Commun. 1998 Apr 28;245(3):894-9
pubmed: 9588211
Nature. 1988 Mar 31;332(6163):411-5
pubmed: 2451132
J Biol Chem. 2013 Feb 22;288(8):5606-15
pubmed: 23283972
Neurosci Lett. 2014 Apr 17;565:39-41
pubmed: 24128880
Br J Pharmacol. 1995 Nov;116(5):2441-6
pubmed: 8581282
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8333-8
pubmed: 15923260
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4892-6
pubmed: 8197152
Stroke. 1997 Oct;28(10):1951-5
pubmed: 9341702
Prog Neurobiol. 2016 Sep;144:103-20
pubmed: 26455456
Nat Genet. 1996 Apr;12(4):445-7
pubmed: 8630503
J Neurochem. 2020 Aug;154(3):330-348
pubmed: 31957020
J Biol Chem. 1989 Sep 5;264(25):14613-6
pubmed: 2768235
J Pharmacol Exp Ther. 1994 Jul;270(1):228-35
pubmed: 8035319
Life Sci. 1992;50(4):247-55
pubmed: 1310132
J Neuroinflammation. 2012 Jul 11;9:169
pubmed: 22784881
Infection. 1999;27(4-5):244-7
pubmed: 10885834
J Neurosurg. 1992 Jul;77(1):96-100
pubmed: 1607979
Brain Res. 1993 Jan 15;600(2):201-7
pubmed: 7679602
Neuropharmacology. 2020 Sep 15;175:108182
pubmed: 32561219
J Neurochem. 2003 Jul;86(1):246-54
pubmed: 12807444
J Neuroophthalmol. 2001 Mar;21(1):37-8
pubmed: 11315981
J Pain. 2009 Jan;10(1):4-28
pubmed: 19111868
Shock. 2007 Jun;27(6):610-4
pubmed: 17505299
Biochem Biophys Res Commun. 2003 Apr 18;303(4):1101-5
pubmed: 12684049
J Histochem Cytochem. 2000 May;48(5):699-707
pubmed: 10769054
Brain Res. 1994 Sep 26;658(1-2):179-84
pubmed: 7834340
J Neurosci. 2008 Jul 9;28(28):7231-43
pubmed: 18614693
Neurobiol Dis. 2014 May;65:160-71
pubmed: 24423643
Exp Neurol. 2003 Mar;180(1):1-13
pubmed: 12668144
J Neurosci. 2008 Mar 5;28(10):2394-408
pubmed: 18322086
Nat Commun. 2020 May 1;11(1):2138
pubmed: 32358570
Biochem Biophys Res Commun. 1992 Apr 30;184(2):953-9
pubmed: 1315540
J Neurosci Res. 2005 Jun 15;80(6):809-16
pubmed: 15898104
J Clin Invest. 2013 Jun;123(6):2643-53
pubmed: 23676500
J Neurosci. 1997 Aug 15;17(16):6203-12
pubmed: 9236231
J Neuroinflammation. 2013 Apr 30;10:51
pubmed: 23627909
Neurosci Lett. 2019 Jan 10;689:45-55
pubmed: 30025833
Glia. 2012 Dec;60(12):1954-63
pubmed: 22927341
J Cardiovasc Pharmacol. 1998;31 Suppl 1:S370-2
pubmed: 9595485

Auteurs

Yutaka Koyama (Y)

Laboratory of Pharmacology, Kobe Pharmaceutical University, 4-19-1 Motoyama-Kita Higashinada, Kobe 668-8558, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH